Orange, CA, United States of America

Rakesh Tiwari

This inventor holds 1 USPTO granted patent. Top assignee: Chapman University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rakesh Tiwari. Retrieved from https://idiyas.com/inventor/rakesh-tiwari-vkdj8b1e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rakesh Tiwari: Innovator in Targeted Drug Delivery Systems

Introduction

Rakesh Tiwari is a notable inventor based in Orange, California. He has made significant contributions to the field of drug delivery systems, particularly in the development of targeted peptide-drug conjugates. His innovative work aims to enhance the efficacy of chemotherapeutic agents in cancer treatment.

Latest Patents

Rakesh Tiwari holds 1 patent for his invention titled "Targeted peptide-drug conjugates." This patent describes drug delivery systems that combine a peptide targeting agent with a pharmaceutical agent. The systems are designed for the effective delivery of chemotherapeutic agents, providing new methods for treating cancer through the administration of these advanced drug delivery systems.

Career Highlights

Rakesh Tiwari is affiliated with Chapman University, where he continues to engage in research and development in the field of drug delivery. His work is characterized by a commitment to improving cancer treatment methodologies through innovative approaches.

Collaborations

Rakesh collaborates with esteemed colleagues, including Parvin Mahdipoor and Khalid Zoghebi. Their combined expertise contributes to the advancement of research in targeted drug delivery systems.

Conclusion

Rakesh Tiwari's contributions to the field of drug delivery systems exemplify the impact of innovation in medical science. His work not only enhances the effectiveness of cancer treatments but also showcases the importance of collaboration in research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…